Fluticasone furoate for the treatment of childhood asthma

Hanna Phan1, Mark A Brown

  • 1Department of Pharmacy Practice and Science, University of Arizona Colleges of Pharmacy and Medicine, Tucson, AZ, USA.

Insights

Once-daily inhaled fluticasone furoate simplifies asthma management for children. This approach may improve adherence and outcomes, especially for adolescents transitioning to self-care.

Area of Science:

  • Pediatric Pulmonology
  • Pharmacology
  • Asthma Management

Background:

  • Inhaled corticosteroids are beneficial for childhood asthma.
  • Poor adherence is common, particularly in adolescents.
  • Transition to self-management poses adherence challenges.

Purpose of the Study:

  • To review the pharmacology, safety, and efficacy of fluticasone furoate for childhood asthma.
  • To assess the potential of once-daily dosing to improve adherence.
  • To identify areas for future research in younger children.

Main Methods:

  • Review of existing literature on fluticasone furoate.
  • Analysis of pharmacological properties.
  • Evaluation of safety and efficacy data.

Main Results:

  • Once-daily inhaled fluticasone furoate simplifies asthma therapy.
  • Potential for improved adherence and outcomes in children and adolescents.
  • Further study needed for safety and growth in younger populations.

Conclusions:

  • Fluticasone furoate offers a simplified treatment option for childhood asthma.
  • Adherence improvement is a key potential benefit.
  • Ongoing research should focus on pediatric safety and efficacy.

Related Concept Videos

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
2.0K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
2.3K
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
4.1K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.7K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.2K